<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220615055179N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-14</date_registration>
      <primary_sponsor>Muhammad Nawaz Sharif University of Agriculture</primary_sponsor>
      <public_title>Formulation of Polyherbal Gel and Evaluation of Anti-nociceptive and Anti-inflammatory Activities</public_title>
      <acronym></acronym>
      <scientific_title>Formulation of Polyherbal Gel and its Evaluation for Anti-nociceptive and Anti-inflammatory Activities in Sports Injuries with superficial massage and phonophoresis in comparison with diclofenac</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-03-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>200</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64171</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: NPRS and WOMAC scales used for evaluation of anti-nociceptive and anti-inflammatory activities in muscular and soft tissue injuries, Randomization description: The lottery method was used for the randomization of participants into four groups in which the names of participants wrote on slips and put their name slips in the box, then selected independently by the lottery method, Blinding description: The participants were blinded.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Muscular injuries.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group-1: The first group received topical application of polyherbal gel, formulated from aqueous-methanolic (30:70) extracts Cinnamomum verum (2.8%), Curcuma longa (2.8%), Zingiber officinale (1.4%), Syzgium aromaticum (2.8%), Olea europaea (2.8%), Trachyspermum ammi (2.8%), Linum usitatissimum (2.8%), Sesamum indicum (2.8%), and Mentha piperita (1.2%), through phonophoresis with therapeutic ultrasound (continuous mode, 1 MH, 0.8W/cm2), on the affected areas of participants. The gel was used once and the data was collected through Numeric pain rating  and The Western Ontario and McMaster Universities Arthritis Index scales. Intervention 2: Intervention group-2:  The second group received topical application of polyherbal gel, formulated from aqueous-methanolic (30:70) extracts Cinnamomum verum (2.8%), Curcuma longa (2.8%), Zingiber officinale (1.4%), Syzgium aromaticum (2.8%), Olea europaea (2.8%), Trachyspermum ammi (2.8%), Linum usitatissimum (2.8%), Sesamum indicum (2.8%), and Mentha piperita (1.2%), through superficial massage on effected areas of participants. The gel was used once and the data was collected through NPRS and WOMAC scales. Intervention 3: Control group-1:The third group received diclofenac diethyl-ammonium 1% gel through phonophoresis with therapeutic ultrasound (continuous mode, 1 MH, 0.8W/cm2) on affected areas of participants. The gel was used once and the data was collected through NPRS and WOMAC scales. Intervention 4: Control group-2: The fourth group received diclofenac diethyl-ammonium 1% gel as control group-2 respectively through superficial massage on the affected areas of participants. The gel was used once and the data was collected through NPRS and WOMAC scales.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Imran Ahmad Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Agriculture Complex, Old Shuja Abad Road</address>
        <city>Multan</city>
        <country1>Pakistan</country1>
        <zip>66000</zip>
        <telephone>+92 333 6120602</telephone>
        <email>imranahmadkhandurrani@gmail.com</email>
        <affiliation>Muhammad Nawaz Sharif University of Agriculture</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muhammad Asif Raza</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Agriculture Complex, Old Shuja Abad Road</address>
        <city>Multan</city>
        <country1>Pakistan</country1>
        <zip>66000</zip>
        <telephone>+92 333 6120602</telephone>
        <email>asif.raza@edu.pk</email>
        <affiliation>Muhammad Nawaz Sharif University of Agriculture, Multan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1st and 2nd grade soft tissue injuries
16-70 years
Both gender</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Any type of allergy from the ingredients used for polyherbal gel formulation
Skin problem
Cancer
Diabetic peripheral neuropathy
Other neurological disorders
Any type of bone fractures
Open injuries
Patients with casts
Patients with splints</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T14.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Primary disorders of muscles</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group-1: The first group received topical application of polyherbal gel, formulated from aqueous-methanolic (30:70) extracts Cinnamomum verum (2.8%), Curcuma longa (2.8%), Zingiber officinale (1.4%), Syzgium aromaticum (2.8%), Olea europaea (2.8%), Trachyspermum ammi (2.8%), Linum usitatissimum (2.8%), Sesamum indicum (2.8%), and Mentha piperita (1.2%), through phonophoresis with therapeutic ultrasound (continuous mode, 1 MH, 0.8W/cm2), on the affected areas of participants. The gel was used once and the data was collected through Numeric pain rating  and The Western Ontario and McMaster Universities Arthritis Index scales.</i_keyword>
      <i_keyword>Intervention group-2:  The second group received topical application of polyherbal gel, formulated from aqueous-methanolic (30:70) extracts Cinnamomum verum (2.8%), Curcuma longa (2.8%), Zingiber officinale (1.4%), Syzgium aromaticum (2.8%), Olea europaea (2.8%), Trachyspermum ammi (2.8%), Linum usitatissimum (2.8%), Sesamum indicum (2.8%), and Mentha piperita (1.2%), through superficial massage on effected areas of participants. The gel was used once and the data was collected through NPRS and WOMAC scales.</i_keyword>
      <i_keyword>Control group-1:The third group received diclofenac diethyl-ammonium 1% gel through phonophoresis with therapeutic ultrasound (continuous mode, 1 MH, 0.8W/cm2) on affected areas of participants. The gel was used once and the data was collected through NPRS and WOMAC scales.</i_keyword>
      <i_keyword>Control group-2: The fourth group received diclofenac diethyl-ammonium 1% gel as control group-2 respectively through superficial massage on the affected areas of participants. The gel was used once and the data was collected through NPRS and WOMAC scales.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: pre and post evaluation. Method of measurement: Numeric pain rating scale (NPRS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Activities of daily living. Timepoint: Pre and post evaluation. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale.</sec_outcome>
      <sec_outcome>Stiffness. Timepoint: Pre and post evaluation. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Muhammad Nawaz Sharif University of Agriculture</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-10</approval_date>
        <contact_name>The Institutional Ethical Committee of Muhammad Institute of Medical and Allied Sciences, Multan</contact_name>
        <contact_address>HBL street near Sabzazar metro station Multan Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
